Format

Send to

Choose Destination
See comment in PubMed Commons below
Methods Mol Biol. 2014;1139:131-44. doi: 10.1007/978-1-4939-0345-0_12.

Fast monocyte-derived dendritic cell-based immunotherapy.

Author information

1
Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt.

Abstract

Recent reports have described a new strategy for differentiation and maturation of monocyte (Mo)-derived dendritic cells (DC) within only 48-72 h of in vitro culture (fast-DC). Mature fast-DC are as effective as mature standard-DC (generated in 7-10 days of in vitro culture) in priming and propagation of antigen-specific T-cell responses. The use of fast-DC not only reduces labor and supply cost, as well as workload and time, but also increases the DC yield from Mo, which may facilitate DC-based immunotherapy for cancer patients. Detailed protocols for generation, pulsing with different antigen sources, and transduction with adenoviral vector of Mo-derived mature fast-DC as well as using of fast-DC for priming and propagation of antigen-specific cytotoxic T-cell effectors will be described here.

PMID:
24619676
DOI:
10.1007/978-1-4939-0345-0_12
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center